基于电子健康记录数据的自更新痛风登记系统的开发与验证
研究基于某三级学术医院2013–2022年电子健康记录开发自动痛风登记系统,采用六项标准筛选,通过病历复核评估阳性与阴性预测值。联合关节穿刺或问题列表诊断或其他标准≥2项构建的登记系统纳入5138例患者,阳性预测值92.4%(95%CI 88.5%–95.0%),阴性预测值94.3%(95%CI 91.9%–96.0%)。
要点
- 联合关节穿刺或问题列表诊断或其他标准≥2项构建的痛风登记系统阳性预测值92.4%(95%CI 88.5%–95.0%)。
- 该登记系统阴性预测值94.3%(95%CI 91.9%–96.0%),门诊与住院患者中相近。
- 痛风发病率为2.9/1000人年,自COVID-19大流行起下降30%。
核心结论
- 基于电子健康记录的自动痛风登记系统可行、有效,可用于评估和改善痛风管理。
- 该登记系统揭示了自COVID-19大流行以来痛风存在明显的诊断不足或报告不足。
研究设计与样本
- 分析某三级学术医院2013–2022年所有18岁以上患者的电子健康记录,基于六项标准构建自动痛风登记系统。
- 六项标准包括:国际疾病分类第10版痛风诊断、降尿酸治疗处方、关节穿刺中单钠尿酸盐结晶、问题列表中的痛风相关术语、临床报告或影像报告。
- 通过病历复核评估查询的阳性预测值和阴性预测值。
主要发现
- 在2 110 902例门诊和住院患者中,10 289例至少符合一项痛风标准。
- 联合关节穿刺或问题列表诊断或其他标准≥2项构建的登记系统纳入5138例患者,阳性预测值92.4%(95%CI 88.5%–95.0%),阴性预测值94.3%(95%CI 91.9%–96.0%)。
- 阳性预测值和阴性预测值在门诊与住院患者中相近。
- 痛风发病率为2.9/1000人年,自COVID-19大流行起下降30%。
- 痛风患者平均年龄71.2岁(SD 14.9),主要为男性(76.5%),超重(69.5%),多病共存(平均合并症数3,IQR 1–5)。
关键数值与推荐
- 57.4%的患者接受过降尿酸治疗。
- 6.7%的患者痛风导致住院或一年内≥2次发作。
- 32.9%的患者接受过风湿科会诊。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To develop an automatic gout register from electronic health records (EHRs) data. METHODS: We analysed the EHR of all patients >18 years old from a tertiary academic hospital (2013-2022) based on six criteria: International Classification of Diseases 10 gout diagnosis, urate-lowering therapy prescription, monosodium urate crystals in joint aspiration and gout-related terms in problem lists, clinical or imaging reports. We assessed the positive and negative predictive value (PPV and NPV) of the query by chart reviews. RESULTS: Of 2 110 902 outpatients and inpatients, 10 289 had at least one criterion for gout. The combination of joint aspiration OR diagnostic in the problem list OR≥2 other criteria created a register of 5138 patients, with a PPV of 92.4% (95% CI 88.5% to 95.0%) and an NPV of 94.3% (95% CI 91.9% to 96.0%). PPV and NPV were similar among outpatients and inpatients. Incidence was 2.9 per 1000 person-year and dropped by 30% from the COVID-19 pandemic onward. Patients with gout were on average 71.2 years old (SD 14.9), mainly male (76.5%), overweight (69.5%) and polymorbid (mean number of comorbidities of 3, IQR 1-5). More than half (57.4%) had received a urate-lowering treatment, 6.7% had a gout that led to a hospitalisation or ≥2 flares within a year and 32.9% received a rheumatology consultation. CONCLUSION: An automatic EHR-based gout register is feasible, valid and could be used to evaluate and improve gout management. Interestingly, the register uncovered a marked underdiagnosis or under-reporting of gout since the COVID-19 pandemic.
引用
- Bürgisser N, Mongin D, Mehouachi S, et al. Development and validation of a self-updating gout register from electronic health records data. RMD Open. 2024. PMID: 38663884. doi:10.1136/rmdopen-2024-004120
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。